#vaccines

Endpoints News नुसार, FDA आपल्या Center for Biologics Evaluation and Research साठी नवीन प्रमुख निवडण्याच्या जवळ पोहोचला आहे, ज्याचा लसी आणि जैविक नियमनावर परिणाम होऊ शकतो.

A newly published charter for the CDC’s vaccine advisory panel adds an explicit focus on vaccine safety after a judge suspended most Trump administration appointments to the committee.

A large trial in India found two new tuberculosis vaccines were safe in adults and children, but neither delivered broad protection against all forms of TB.

Federal health officials are changing eligibility rules for a key vaccine advisory panel after a judge ruled that many current members do not meet the required qualifications.

A new pediatric analysis spanning the 2021 to 2024 influenza seasons found that vaccine protection shifted from year to year but still reduced both hospitalizations and outpatient visits.

A new study suggests seasonal influenza vaccination may help prepare the immune system beyond the viruses targeted in a given year, adding a longer-view argument for routine immunization.

A long-stagnant field is moving again as tuberculosis drug and vaccine development reaches its broadest pipeline on record, raising the prospect of shorter treatments and the first new vaccine class in a century.

सुई न वापरता दिलेली नाकातून घेणारी लस चूहांना श्वसन रोगजनक बॅक्टेरिया आणि विषाणूंच्या विविध श्रेणीविरुद्ध व्यापक संरक्षण दिले, मानव सार्वभौमिक लस अभ्यासांसाठी मार्ग तयार केले.

शास्त्रज्ञांनी DoriVac विकसित केले आहे, हे DNA नॅनोस्ट्रक्चर लस प्लॅटफॉर्म सुरुवातीच्या अभ्यासांमध्ये mRNA लस पेक्षा अधिक मजबूत आणि अधिक टिकाऊ प्रतिरक्षा प्रतिक्रिया तयार करते, HIV, Ebola, आणि COVID-19 ला लक्ष्य करून.

A growing body of research suggests that the shingles vaccine does more than prevent a painful rash — it may significantly reduce the risk of dementia, including Alzheimer's disease, and even slow biological aging. The latest studies add to evidence that has been accumulating for years.

With nearly 1,000 confirmed measles cases in 2026 spread across close to half of U.S. states, public health officials are sounding the alarm about a broader crisis. Declining vaccination rates could open the door to resurgences of mumps, hepatitis B, and other diseases once thought conquered.